Focus on Cognitive Impairment in Heart Failure

Cognitive impairment is prevalent in patients living with heart failure and was recently shown to negatively impact functional abilities, life expectancy, medication management and patient self-care. This seminar identifies key takeaways from the Cognitive Impairment in Heart Failure: A Heart Failure Society of America Scientific Statement.

Could Statins Be The Next Breakthrough HFpEF Treatment?

Statins are one of the most-prescribed drug classes in the world, but there’s still little data on their heart failure benefits, especially for HFpEF patients. This article reviews a recent JAMA study that suggests statins might have a massive impact on HFpEF care, even among patients who do not have atherosclerosis.

The Role of Screening, Addressing Cognitive Impairment in Heart Failure Management

Eiran Gorodeski, MD, MPH, Parag Goyal, MD, MSc, and James Fang, MD, discuss the HFSA's recent scientific statement on the prevalence and impact of cognitive impairment on the management of heart failure.

Race Doesn't Impact Cardiovascular Risk Calculations

This article is about a recent study in the Journal of the American Medical Association Cardiology supporting a growing body of evidence questioning the use of race in medical decision-making.

Taking Low-Dose Aspirin Every Day May Increase Risk of Anemia in Older Adults

This article describes how daily low-dose aspirin use in older adults may increase the risk of anemia. This suggests that older adults who use aspirin regularly should be aware of symptoms of anemia, and may require additional monitoring by healthcare providers.

Heart Failure With Preserved EF: New Insights, Respect for Exercise?

Supervised exercise shows promise in improving outcomes for patients with heart failure with preserved ejection fraction (HFpEF), according to discussions at the American Geriatrics Society (AGS) 2023 Annual Scientific Meeting. It was noted that supervised exercise training consistently enhances exercise capacity in HFpEF patients. The meeting also addressed topics such as HFpEF epidemiology, diagnosis, pharmacologic management, and disparities in access to care.

Parag Goyal, MD, MSc on Patient Priorities Care

Dr. Goyal speaks on the importance of using a patient-priorities aligned approach for older adults with cardiovascular disease.

Can N-of-1 trials inform deprescribing practices?

Dr. Goyal discusses with the US Deprescribing Research Network (USDeN) a narrative review written with colleagues that describes an innovative patient-centred approach to deprescribing-N-of-1 trials published in the British Journal of Clinical Pharmacology.

Post-Operative Atrial Fibrillation Associated with Higher Risk for HF

This article details a study published in the European Heart Journal in which Dr. Goyal and colleagues document the increased risk for hospitalization for heart failure among patients undergoing both cardiac and noncardiac surgery.

The dangers of polypharmacy and the case for deprescribing in older adults

This article describes the practice of deprescribing in real-world clinical practice. The story highlights, among other studies, an innovative, NIA-funded pilot study led by Dr. Goyal that focuses on increasing patient confidence regarding the decision to continue or discontinue medications.

Embracing the Right Polypharmacy in Older Adults With HF

Dr. Goyal speaks with Medscape on the importance of reviewing the totality of medications presibed for older heart failure patients. He discusses his article he co-authored in Circulation: Heart Failure detailing the growing medication burden amongst this population over time.

Many Older Americans With Heart Failure Take 10 or More Meds

Dr. Goyal talks with US News & World Report about his study published in Circulation: Heart Failure describing the growing medication burden among hospitalized older adults with heart failure.

Polypharmacy significantly increased in HF hospitalizations from 2003 to 2014

This article details a study in which Dr. Goyal and colleagues document the growing number of medications prescribed to older adults hospitalized with heart failure and the importance of developing strategies to mitigate potential inadvertent negative effects.

Dr. Parag Goyal Receives The Paul B. Beeson Emerging Leaders Career Development Award in Aging

This article discusses Dr. Goyal winning a prestigious 5-year research grant to support the development of a strategy for deprescribing medication in older adults with heart failure.

Parag Goyal, MD, MSc, on How a New Risk Calculator Can Reduce CV Readmission After a Heart Failure Hospitalization

In this podcast, Dr. Goyal provides an overview of the risk calculator and explains how it can play a role in meeting the “need to move toward a more tailored, personalized approach” to postdischarge therapy.

BP Control in Older Patients Feasible with Medication Reduction

In this article, Dr. Goyal shares his perspective on deprescribing and his thoughts on the study of the effect of deprescribing.

Heart Failure Beat Podcast: Provider Series

In this podcast, Dr. Goyal discusses virtual visits for the care of patients with heart failure in the era of COVID-19.

Many Cardiologists Support Deprescription as a Means to Reduce Polypharmacy

This article details a study in which Dr. Goyal and colleagues surveyed geriatricians, general internists and cardiologists about their views on the practice of deprescribing.

Geriatricians, Internists, and Cardiologists Surveyed About Deprescribing

This article speaks on polypharmacy and its effects. It also mentions a study conducted by Dr. Goyal and colleagues about deprescribing, a method to combat polypharmacy.

Drugs That Worsen Heart Failure Common in Hospitalized HF

Dr. Goyal talks with Medscape Cardiology about his study published in JACC Heart Failure describing patterns of harmful medication prescribing during heart failure hospitalizations.

Medications That Worsen Heart Failure Often Initiated, Continued After Hospitalization

Dr. Goyal discusses with Cardiology Today the alarming findings detailed in his JACC: Heart Failure article of medications that worsen heart failure being continued or prescribed after hospitalization due to heart failure.

At Your Service: Fewer Heart Failure Readmissions After Cardiology vs Hospitalist Care

Dr. Goyal speaks with Medscape on the importance of coordination amongst hospitalists and cardiologists in the treatment of heart failure patients. He discusses his article he co-authored in the American Journal of Cardiology detailing the decreased likelihood of 30-day readmission of heart failure patients admitted to the Cardiology services as compared to the General Medicine services.

Weill Cornell Medicine
The Program for the Care and Study of the Aging Heart

1305 York Ave, 8th floor
New York, NY 10021
Phone: (646) 962-7571
Fax: (212) 746-6665